_version_ 1783690801138630656
author Kresbach, Catena
Dorostkar, Mario M.
Suwala, Abigail K.
Wefers, Annika K.
Schweizer, Leonille
Engertsberger, Lara
Bison, Brigitte
Mynarek, Martin
Kloth-Stachnau, Katja
Spohn, Michael
von Deimling, Andreas
Benesch, Martin
Hagel, Christian
Mautner, Viktor-F.
Rutkowski, Stefan
Schüller, Ulrich
author_facet Kresbach, Catena
Dorostkar, Mario M.
Suwala, Abigail K.
Wefers, Annika K.
Schweizer, Leonille
Engertsberger, Lara
Bison, Brigitte
Mynarek, Martin
Kloth-Stachnau, Katja
Spohn, Michael
von Deimling, Andreas
Benesch, Martin
Hagel, Christian
Mautner, Viktor-F.
Rutkowski, Stefan
Schüller, Ulrich
author_sort Kresbach, Catena
collection PubMed
description
format Online
Article
Text
id pubmed-8113165
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81131652021-05-13 Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype Kresbach, Catena Dorostkar, Mario M. Suwala, Abigail K. Wefers, Annika K. Schweizer, Leonille Engertsberger, Lara Bison, Brigitte Mynarek, Martin Kloth-Stachnau, Katja Spohn, Michael von Deimling, Andreas Benesch, Martin Hagel, Christian Mautner, Viktor-F. Rutkowski, Stefan Schüller, Ulrich Acta Neuropathol Correspondence Springer Berlin Heidelberg 2021-04-12 2021 /pmc/articles/PMC8113165/ /pubmed/33844070 http://dx.doi.org/10.1007/s00401-021-02304-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Kresbach, Catena
Dorostkar, Mario M.
Suwala, Abigail K.
Wefers, Annika K.
Schweizer, Leonille
Engertsberger, Lara
Bison, Brigitte
Mynarek, Martin
Kloth-Stachnau, Katja
Spohn, Michael
von Deimling, Andreas
Benesch, Martin
Hagel, Christian
Mautner, Viktor-F.
Rutkowski, Stefan
Schüller, Ulrich
Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype
title Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype
title_full Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype
title_fullStr Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype
title_full_unstemmed Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype
title_short Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype
title_sort neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113165/
https://www.ncbi.nlm.nih.gov/pubmed/33844070
http://dx.doi.org/10.1007/s00401-021-02304-4
work_keys_str_mv AT kresbachcatena neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT dorostkarmariom neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT suwalaabigailk neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT wefersannikak neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT schweizerleonille neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT engertsbergerlara neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT bisonbrigitte neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT mynarekmartin neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT klothstachnaukatja neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT spohnmichael neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT vondeimlingandreas neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT beneschmartin neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT hagelchristian neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT mautnerviktorf neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT rutkowskistefan neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype
AT schullerulrich neurofibromatosistype2predisposestoependymomasofvariouslocalizationhistologyandmolecularsubtype